Sanara Capital

Sanara Capital is a dedicated Health-Tech fund established in 2023, specializing in Digital Health, Bio-Convergence, and Medical Devices. The fund focuses on Series A and B financing rounds for Israeli-related startups operating both in Israel and internationally. Sanara Capital serves as a follow-on fund to Sanara Ventures, a seed-stage investment platform established in 2015 and backed by industry leaders Philips and Teva, with nearly 20 active portfolio companies across both funds. The fund's investment strategy emphasizes supporting innovative healthcare technologies that address significant challenges in the medical field. By leveraging its strong industry connections and expertise, Sanara Capital aims to accelerate the growth of its portfolio companies, facilitating their entry into global markets and enhancing their impact on patient care. The fund's approach combines financial support with strategic guidance, fostering an ecosystem that nurtures healthcare innovation. Sanara Capital's team comprises professionals with extensive experience in healthcare, technology, and finance, enabling the fund to provide comprehensive support to its portfolio companies. The fund's commitment to advancing healthcare solutions is reflected in its active participation in industry events and collaborations with leading healthcare institutions, underscoring its dedication to driving meaningful change in the healthcare sector.

Innovative healthcare technologies, Israeli-related startups, Digital Health, Bio-Convergence, Medical Devices